Dihexa offers a mechanistically intriguing but unvalidated probe for HGF/c-Met neurobiology, with the critical caveat that its core published evidence is under question
In doing so, we advocate for a paradigm that moves beyond traditional indications, embracing the full spectrum of GLP-1R agonists in areas such as primary prevention, microvascular protection, and metabolic liver disease, and metabolic disorders that include cardio-kidney-metabolic (CKM) syndromea systemic disorder characterized by interrelated metabolic, renal, and cardiovascular dysfunction and a broader cardio-renal-metabolic axis that includes central obesity, insulin resistance, dyslipidemia, hypertension, and pre-diabetic states
This is potentially a better alternative for individuals whose goal is weight management
A cjc 1295 ipamorelin cycle runs 1 to 3 months on, followed by 2 to 3 months off
Please see Prescribing Information for Wegovy